ArticleNursing research2026
Pilot Study of Oral Microbiome and Psychoneurological Symptom Cluster in Breast Cancer.
Article in Nursing research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundWomen with breast cancer experience high symptom burden from a psychoneurological symptom cluster consisting of fatigue, anxiety, depression, sleep disturbances, and pain. Interventions to manage this symptom cluster are limited as its etiology is not well understood. One system that has been linked with this symptom cluster in both healthy and other chronically ill populations but has not been explored in breast cancer is the oral microbiome.
objectiveWe examined differences in oral microbiome diversity and composition between women with breast cancer who reported high versus low levels of psychoneurological symptoms.
methodsOral microbial changes based on bacterial diversity and relative abundance were estimated from 16S rRNA gene sequencing data of oral tongue swabs from 22 women with breast cancer prior to mastectomy. The fatigue, anxiety, depression, sleep disturbance, and pain interference subscales of the Patient-Reported Outcomes Measurement Information System 29 scale were used to calculate the symptom groups.
resultsObserved amplicon sequence variants were lower in the high-symptom group than in the low-symptom group, but no differences between groups were seen in other alpha diversity metrics (Shannon, Inverse Simpson). No differences in beta diversity were found between the high- and low-symptom groups. For differential abundance, three genera were more abundant in the high-symptom group than the low-symptom group: Aggregatibacter, Lautropia, and Prevotellaceae UCG-001. DISCUSSION: Preliminary associations were identified between the psychoneurological symptom cluster and oral microbiome diversity and composition. Of the differentially abundant genera, Lautropia has been previously linked with anxiety, and Aggregatibacter has been researched due to its pro-inflammatory potential. As inflammation is posited to influence psychoneurological symptom cluster severity, further research on the relationship between the oral microbiome and the psychoneurological symptom cluster, specifically in relation to potential causal mechanisms, is warranted. Enhanced insight into this relationship could inform targeted interventions to improve the symptom experience for women with breast cancer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.